Premium Nahrungsergänzungsmittel | artgerecht

L50.8 Other Urticaria – Causes & Treatment

L50.8 is the ICD-10 code for other urticaria, covering forms of hives not classified elsewhere. It is a skin condition characterised by wheals, redness, and itching.

Regular tips about health Regular tips about health

Things worth knowing about "L50.8"

L50.8 is the ICD-10 code for other urticaria, covering forms of hives not classified elsewhere. It is a skin condition characterised by wheals, redness, and itching.

What is L50.8?

The ICD-10 code L50.8 refers to other urticaria – forms of hives that do not fit into the more specifically defined subcategories L50.0 to L50.6. Urticaria is a common skin condition characterised by the sudden appearance of raised, itchy welts (wheals) on the skin surface.

Causes

The causes of urticaria classified under L50.8 are diverse and not always clearly identifiable:

Infections: Viral or bacterial infections can trigger urticaria.
Medications: Certain drugs such as antibiotics, NSAIDs, or contrast agents.
Foods and additives: E.g. peanuts, shellfish, preservatives.
Contact allergens: Direct skin contact with allergy-inducing substances.
Autoimmune processes: The immune system targets the body's own structures.
Idiopathic causes: In many cases, no specific trigger can be identified.

Symptoms

Typical symptoms of urticaria include:

Wheals: Raised, red or pale skin lesions that vary in size.
Itching: Often intense, burning itch in the affected areas.
Angioedema: Deeper swelling of the skin, frequently affecting the face, lips, or eyelids.
Transient nature: Individual wheals typically resolve within 24 hours.

Diagnosis

The diagnosis of urticaria under L50.8 is established through:

Medical history: Detailed assessment of triggers, comorbidities, and medication use.
Physical examination: Evaluation of skin changes by a dermatologist.
Allergy testing: Skin prick tests or specific IgE measurement in the blood.
Laboratory tests: Full blood count, inflammatory markers, thyroid levels, and autoantibodies if indicated.
Provocation tests: Targeted testing for physical or other specific triggers.

Treatment

Treatment depends on the underlying cause and severity of the condition:

General Measures

Identification and avoidance of known triggers.
Cooling measures to relieve itching (e.g. cool compresses).

Pharmacological Therapy

Antihistamines (H1-blockers): First-line treatment; modern, non-sedating antihistamines (e.g. cetirizine, loratadine) are preferred.
Corticosteroids: Used short-term for severe acute episodes.
Omalizumab: A biologic agent for severe, antihistamine-refractory chronic urticaria.
Causal therapy: Treatment of the underlying condition if identified.

References

Zuberbier T. et al. - The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria. Allergy. 2022;77(3):734-766.
World Health Organization (WHO) - ICD-10: International Statistical Classification of Diseases and Related Health Problems, 10th Revision. Chapter XII: Diseases of the skin and subcutaneous tissue (L00-L99).
Magerl M. et al. - Urticaria: Guideline of the German Dermatological Society (DDG). AWMF Guidelines Register No. 013-028, 2022.

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.